Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Afinitor recommended for use in the European Union for patients with advanced kidney cancer
Novartis, 06/01/09
Novartis has received a positive opinion from the Committee for Medicinal Products for Human Use supporting European Union approval of Afinitor Tablets for the treatment of patients with advanced renal cell carcinoma.
Related Articles
Trends from 1999 to 2007 in the surgical treatments of kidney cancer in Europe: data from the Veneto Region, Italy
BJU International, 10/14/09
Relevance Score: 68%
Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2
Proceedings of the National Academy of Sciences of the United States of America, 11/11/09
Relevance Score: 67%
In Vivo Imaging of Human Colorectal Cancer Using Radiolabeled Analogs of the Uroguanylin Peptide Hormone
Anticancer Research, 11/10/09
Relevance Score: 67%
Childhood cancer mortality in Europe, 1970–2007
European Journal of Cancer, 10/14/09
Relevance Score: 67%
Renal Metastasis From Primary Colon Cancer on FDG PET-CT
Clinical Nuclear Medicine, 10/06/09
Relevance Score: 67%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Seliciclib in malignancies
Expert Opinion on Investigational Drugs, 11/30/09
Antiangiogenic Drugs in Oncology: A Focus on Drug Safety and the Elderly - A Mini-Review
Gerontology, 11/30/09
Valproic acid restores ERalpha and antiestrogen sensitivity to ERalpha-negative breast cancer cells
Molecular and Cellular Endocrinology, 11/25/09
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Major European regulatory milestone in cardiovascular protection for Micardis : Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients
Boehringer Ingelheim, 11/30/09
Human genome sciences submits biologics license application to fda for zalbin
Human Genome Sciences, 11/30/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Today in Drug/Product Alerts...keeping you current
Receive free subspecialty "5-minute updates" via email
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Archives of Neurology, 11/23/09
Medtronic Receives FDA Warning Letter Following Inspection of Its Mounds View, Minn. Facility
Medtronic, 11/19/09
Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin
Current Medical Research and Opinion, 11/17/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Biphasic insulin aspart in the treatment of type 2 diabetes mellitus
Expert Opinion in Pharmacotherapy, 11/30/09
Pharmacotherapy for obesity
British Journal of Clinical Pharmacology, 11/30/09
Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
International Journal of Women's Health, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


